Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.85 EUR 0.52%
Market Cap: 35.7m EUR
Have any thoughts about
Genoway SA?
Write Note

P/S
Price to Sales

1.6
Current
1.9
Median
7.6
Industry
Lower than median
Lower than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
1.6
=
Market Cap
33.6m EUR
/
Revenue
21.4m EUR
All Countries
Close
Market Cap P/S
FR
Genoway SA
PAR:ALGEN
33.6m EUR 1.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 027 714.7
US
Abbvie Inc
NYSE:ABBV
310.3B USD 5.6
US
Amgen Inc
NASDAQ:AMGN
141.6B USD 4.4
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD 4.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD 9.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 852.6
AU
CSL Ltd
ASX:CSL
134.4B AUD 5.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD 5.6
US
Seagen Inc
F:SGT
39.3B EUR 17.8
NL
argenx SE
XBRU:ARGX
35.8B EUR 19.2
Revenue Growth P/S to Growth
FR
Genoway SA
PAR:ALGEN
Average P/S: 3 457 240.1
1.6
78%
0
FR
Pharnext SCA
OTC:PNEXF
38 027 714.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.6
20%
0.3
US
Amgen Inc
NASDAQ:AMGN
4.4
26%
0.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
10%
0.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
34%
0.3
US
E
Epizyme Inc
F:EPE
1 852.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
23%
0.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.6
23%
0.2
US
S
Seagen Inc
F:SGT
17.8
118%
0.2
NL
argenx SE
XBRU:ARGX
19.2
220%
0.1

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
1.4
2-Years Forward
P/S
1.1
3-Years Forward
P/S
0.9

See Also

Discover More